Literature DB >> 8358717

Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen.

B S Reddy1, A Rivenson.   

Abstract

The inhibitory effect of lyophilized cultures of Bifidobacterium longum on 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced carcinogenesis was investigated in male and female F344 rats. Beginning at 5 weeks of age, male and female rats were divided into various experimental groups and fed one of the high-fat, semipurified diets containing 0 and 0.5% lyophilized cultures of B. longum with or without 125 ppm IQ in the diet. All animals were continued on this regimen until the termination of the study. All animals were necropsied during the 58th week. The results indicated that dietary B. longum significantly inhibited the IQ-induced incidence (percentage of animals with tumors) of colon (100% inhibition) and liver (80% inhibition) tumors and multiplicity (tumors/animal) of colon, liver, and small intestinal tumors in male rats. In female rats, dietary supplementation of Bifidobacterium cultures also suppressed the IQ-induced mammary carcinogenesis to 50% and liver carcinogenesis to 27% of those observed in animals fed the control diet, but the differences did not reach a statistical significance at P < 0.05; however, the mammary tumor multiplicity (tumors/animal) was significantly (P < 0.05) inhibited in female rats fed the diet containing Bifidobacterium cultures. These findings suggest that Bifidobacterium supplements in the diet inhibit IQ-induced colon and liver tumors and to a lesser extent mammary tumors in F344 rats.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358717

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

Review 1.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  BMJ       Date:  1999-04-10

2.  Antimutagenicity of milk fermented by Enterococcus faecium.

Authors:  A Belicová; J Krajcovic; J Dobias; L Ebringer
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

Review 3.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

4.  Effects of some natural immunomodulatory compounds in combination with thalidomide on survival rate and tumor size in fibrosarcoma-bearing mice.

Authors:  Reza Aghebati Maleki; Dariush Shanehbandi; Saeed Sadigh Eteghad; Habib Zarredar; Fatemeh Zare Shahneh; Leili Aghebati Maleki; Mehrnosh Samavati; Hamed Asadi; Seyed Ehsan Mosavi; Afshin Habibzadeh; Mozhdeh Mohammadian; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2014-08-25

Review 5.  Do probiotics have a therapeutic role in gastroenterology?

Authors:  Jimmy K Limdi; Catherine O'Neill; John McLaughlin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

6.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  West J Med       Date:  1999-09

7.  A prospective study of dairy product intake and the risk of hepatocellular carcinoma in U.S. men and women.

Authors:  Wanshui Yang; Jing Sui; Yanan Ma; Tracey G Simon; Dawn Chong; Jeffrey A Meyerhardt; Walter C Willett; Edward L Giovannucci; Andrew T Chan; Xuehong Zhang
Journal:  Int J Cancer       Date:  2019-06-06       Impact factor: 7.396

Review 8.  The intestinal microbiome and surgical disease.

Authors:  Monika A Krezalek; Kinga B Skowron; Kristina L Guyton; Baddr Shakhsheer; Sanjiv Hyoju; John C Alverdy
Journal:  Curr Probl Surg       Date:  2016-06-14       Impact factor: 1.909

Review 9.  Applications of inulin and oligofructose in health and nutrition.

Authors:  Narinder Kaur; Anil K Gupta
Journal:  J Biosci       Date:  2002-12       Impact factor: 1.826

10.  Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer.

Authors:  Marion Lenoir; Silvina Del Carmen; Naima G Cortes-Perez; Daniel Lozano-Ojalvo; Diego Muñoz-Provencio; Florian Chain; Philippe Langella; Alejandra de Moreno de LeBlanc; Jean Guy LeBlanc; Luis G Bermúdez-Humarán
Journal:  J Gastroenterol       Date:  2016-01-09       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.